Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALESA - FR0011490648 - Common Stock

0.74 EUR
0 (-0.54%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALESA. ALESA was compared to 40 industry peers in the Commercial Services & Supplies industry. ALESA has a bad profitability rating. Also its financial health evaluation is rather negative. ALESA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALESA had negative earnings in the past year.
In the past year ALESA had a positive cash flow from operations.
ALESA had negative earnings in each of the past 5 years.
In the past 5 years ALESA always reported negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -12.80%, ALESA is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
ALESA has a Return On Equity of -76.78%. This is in the lower half of the industry: ALESA underperforms 77.50% of its industry peers.
Industry RankSector Rank
ROA -12.8%
ROE -76.78%
ROIC N/A
ROA(3y)-12.2%
ROA(5y)-10.84%
ROE(3y)-51.3%
ROE(5y)-41.65%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

ALESA has a Gross Margin of 64.42%. This is in the better half of the industry: ALESA outperforms 72.50% of its industry peers.
In the last couple of years the Gross Margin of ALESA has grown nicely.
The Profit Margin and Operating Margin are not available for ALESA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

ALESA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALESA remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALESA has been increased compared to 5 years ago.
Compared to 1 year ago, ALESA has a worse debt to assets ratio.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALESA has an Altman-Z score of 0.77. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALESA (0.77) is worse than 70.00% of its industry peers.
ALESA has a debt to FCF ratio of 48.48. This is a negative value and a sign of low solvency as ALESA would need 48.48 years to pay back of all of its debts.
ALESA has a Debt to FCF ratio of 48.48. This is in the lower half of the industry: ALESA underperforms 60.00% of its industry peers.
A Debt/Equity ratio of 4.00 is on the high side and indicates that ALESA has dependencies on debt financing.
The Debt to Equity ratio of ALESA (4.00) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4
Debt/FCF 48.48
Altman-Z 0.77
ROIC/WACCN/A
WACC10.19%
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 4.35 indicates that ALESA has no problem at all paying its short term obligations.
ALESA has a Current ratio of 4.35. This is amongst the best in the industry. ALESA outperforms 95.00% of its industry peers.
A Quick Ratio of 3.92 indicates that ALESA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.92, ALESA belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.35
Quick Ratio 3.92
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.19% over the past year.
ALESA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.19%.
The Revenue has been growing slightly by 5.43% on average over the past years.
EPS 1Y (TTM)6.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.5%
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

ALESA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALESA is valuated cheaply with a Price/Forward Earnings ratio of 1.45.
Based on the Price/Forward Earnings ratio, ALESA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ALESA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE N/A
Fwd PE 1.45
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALESA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.64
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ALESA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALESA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ECOSLOPS

EPA:ALESA (1/2/2026, 7:00:00 PM)

0.74

0 (-0.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-30 2025-10-30
Earnings (Next)04-28 2026-04-28
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.84M
Revenue(TTM)11.36M
Net Income(TTM)-3.07M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.45
P/S 0.34
P/FCF 11.64
P/OCF 3.31
P/B 0.96
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.51
Fwd EY68.9%
FCF(TTM)0.06
FCFY8.59%
OCF(TTM)0.22
OCFY30.2%
SpS2.19
BVpS0.77
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.8%
ROE -76.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.42%
FCFM 2.91%
ROA(3y)-12.2%
ROA(5y)-10.84%
ROE(3y)-51.3%
ROE(5y)-41.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 4
Debt/FCF 48.48
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.35
Quick Ratio 3.92
Altman-Z 0.77
F-Score4
WACC10.19%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.5%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-199.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y194.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.81%
OCF growth 3YN/A
OCF growth 5YN/A

ECOSLOPS / ALESA.PA FAQ

What is the fundamental rating for ALESA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALESA.PA.


What is the valuation status of ECOSLOPS (ALESA.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to ECOSLOPS (ALESA.PA). This can be considered as Fairly Valued.


How profitable is ECOSLOPS (ALESA.PA) stock?

ECOSLOPS (ALESA.PA) has a profitability rating of 1 / 10.


How financially healthy is ECOSLOPS?

The financial health rating of ECOSLOPS (ALESA.PA) is 3 / 10.


What is the expected EPS growth for ECOSLOPS (ALESA.PA) stock?

The Earnings per Share (EPS) of ECOSLOPS (ALESA.PA) is expected to grow by 211.24% in the next year.